AcelRx Pharmaceuticals, Inc. ACRX
0.86 +0.86
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 1.77M | 2.82M | 5.42M | 2.29M | 2.15M | |
| -820.00K | -935.00K | -616.00K | -4.52M | -1.82M | |
| -36.63M | -35.97M | -40.96M | -54.20M | -35.73M | |
| 47.76M | -35.10M | -40.38M | -53.24M | -47.15M | |
| 5.72 | -5.86 | -9.40 | -13.40 | -16.20 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 20.27M | 7.66M | 27.27M | 14.68M | 87.97M | |
| 47.49M | 77.89M | 66.30M | 91.36M | 120.53M | |
| 25.67M | 113.79M | 122.05M | 132.77M | 116.28M | |
| 5.36M | 18.62M | 25.60M | 29.76M | 11.99M | |
| 21.81M | -35.89M | -55.75M | -41.42M | 4.25M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -28.33M | -30.00M | -38.51M | -51.18M | -29.07M | |
| 36.45M | -26.12M | 34.14M | -36.56M | -10.88M | |
| -507.00K | 41.51M | 16.96M | 14.45M | 75.03M | |
| -364.00K | -1.83M | -1.85M | -3.47M | -819.00K | |
| 7.61M | -14.61M | 12.59M | -73.29M | 35.07M |